Identification of dual mTORC1 and mTORC2 inhibitors in melanoma cells: Prodigiosin vs. obatoclax

M. Espona-Fiedler, V. Soto-Cerrato, A. Hosseini, J. M. Lizcano, V. Guallar, R. Quesada, T. Gao, R. Pérez-Tomás

Research output: Contribution to journalArticleResearchpeer-review

46 Citations (Scopus)

Fingerprint Dive into the research topics of 'Identification of dual mTORC1 and mTORC2 inhibitors in melanoma cells: Prodigiosin vs. obatoclax'. Together they form a unique fingerprint.

Chemical Compounds